Merck KGaA sales and marketing update

Merck KGaA's Merck Serono S.A. subsidiary launched Cyanokit hydroxocobalamin to treat known or suspected cyanide poisoning in Japan. The vitamin B12 precursor is marketed in the U.S. and approved in...